EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Choice of fixative affects programmed death‐ligand 1 expression in cell blocks from pleural effusions with metastatic pulmonary adenocarcinoma

Mohammed S I Mansour iD, Louise Pettersson iD, Rita Pedersen, Ulrich Mager, Kim Hejny, Frida Kronqvist, Anna Aronsson, Tomas Seidal, Levent M Akyürek, Ivana Kholová iD

Cancer Cytopathology · 2026

DOI: 10.1002/cncy.70078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2026. Verfasst von Mohammed S I Mansour und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Cytology, Halland Hospital Halmstad, Halmstad, Sweden. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma, B7-H1 Antigen, Pleural Effusion, Malignant. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Regional Research and Development Funding in Region Halland and Region Skåne, Pirkanmaa Wellbeing Region Competitive Research Grant, Sparbanken Foundation in Varberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Programmed death‐ligand 1 (PD‐L1) immunocytochemical (ICC) analysis of cell blocks (CBs) has recently emerged in clinical practice. Unlike standardized immunohistochemistry on formalin‐fixed, paraffin‐embedded tissues, cytology involves various preparation methods and fixatives. This study investigated how various fixatives influence PD‐L1 immunoreactivity in CBs from malignant pleural effusions (MPEs) with metastatic pulmonary adenocarcinoma (AC).

Methods

Thirty‐three MPEs from patients with pulmonary AC were prospectively included. Four matched CBs per case were fixed in four different fixatives and immunostained with three PD‐L1 antibodies. Tumor proportion score and staining intensity were evaluated at multiple cutoffs.

Results

The cytology–cytology correlation of PD‐L1 expression with the antibodies 28‐8, 22C3, and SP263 was assessed in matched CBs fixed in either formalin, PreservCyt, CytoLyt, or CytoRich Red (the latter only in 26 cases). Compared to formalin, PreservCyt and CytoLyt showed moderate concordance at the ≥1% cutoff (Cohen kappa [κ], 0.463–0.535 and 0.57–0.586, respectively), except SP263 with CytoLyt, which demonstrated only fair concordance (κ, 0.382). The corresponding figures for CytoRich Red indicated substantial concordance for 28‐8 and SP263 (κ, 0.601 and 0.669) and very good concordance for 22C3 (κ, 0.806). At the ≥50% cutoff, concordance improved for 28‐8 and 22C3 but remained largely unchanged for SP263. All alcohol‐based fixatives produced significantly weaker PD‐L1 staining intensity than formalin across all antibodies ( p < .001–.007).

Conclusions

PD‐L1 ICC expression in CBs depends on the fixative and antibody used. Alcohol‐based fixatives, particularly with low cutoffs, risk underestimating PD‐L1 positivity, and may contribute to false‐negative results. ICC protocol optimization is essential before diagnostic use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAdenocarcinomaB7-H1 AntigenPleural Effusion, MalignantFixativesTissue FixationHumansFemaleMaleImmunohistochemistryAgedAdenocarcinoma of LungMiddle AgedBiomarkers, TumorProspective StudiesCytodiagnosis

Stichwörter der Autor:innen

CytoLytCytoRich RedPreservCytcell blockcytology–cytology correlationformalinprogrammed death‐ligand 1 (PD‐L1)

Substanzen

B7-H1 AntigenFixativesCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Cytology, Halland Hospital Halmstad, Halmstad, Sweden.
  • Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Department of Bioanalysis, Faculty of Natural Sciences, Kristianstad University, Kristianstad, Sweden.
  • Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.
  • Research and Innovation Centre, Region Halland, Halmstad, Sweden.
  • Division of Respiratory and Internal Medicine, Department of Clinical Medicine, Halland Hospital Halmstad, Halmstad, Sweden.

ORCID-Profile: Mohammed S I Mansour, Louise Pettersson, Ivana Kholová

Förderung

  • Regional Research and Development Funding in Region Halland and Region Skåne
  • Pirkanmaa Wellbeing Region Competitive Research Grant
  • Sparbanken Foundation in Varberg
  • Tampere Tuberculosis Foundation

Zitieren

APA

Mansour, M. S. I., Pettersson, L., Pedersen, R., Mager, U., Hejny, K., Kronqvist, F., Aronsson, A., Seidal, T., Akyürek, L. M., & Kholová, I. (2026). Choice of fixative affects programmed death‐ligand 1 expression in cell blocks from pleural effusions with metastatic pulmonary adenocarcinoma. Cancer Cytopathology. https://doi.org/10.1002/cncy.70078

Vancouver

Mansour MSI, Pettersson L, Pedersen R, Mager U, Hejny K, Kronqvist F, et al. Choice of fixative affects programmed death‐ligand 1 expression in cell blocks from pleural effusions with metastatic pulmonary adenocarcinoma. Cancer Cytopathology. 2026. doi:10.1002/cncy.70078

BibTeX
@article{Mansour2026,
  author = {Mansour, Mohammed S I and Pettersson, Louise and Pedersen, Rita and Mager, Ulrich and Hejny, Kim and Kronqvist, Frida and Aronsson, Anna and Seidal, Tomas and Akyürek, Levent M and Kholová, Ivana},
  title = {Choice of fixative affects programmed death‐ligand 1 expression in cell blocks from pleural effusions with metastatic pulmonary adenocarcinoma},
  journal = {Cancer Cytopathology},
  year = {2026},
  doi = {10.1002/cncy.70078}
}
Kostenlos starten →